Outreach education for integration of HIV/AIDS care, antiretroviral treatment, and tuberculosis care in primary care clinics in South Africa: PALSA PLUS pragmatic cluster randomised trial

Objective To investigate whether PALSA PLUS, an on-site educational outreach programme of non-didactic, case based, iterative clinical education of staff, led by a trainer, can increase access to and comprehensiveness of care for patients with HIV/AIDS. Design Cluster randomised trial. Setting Public primary care clinics offering HIV/AIDS care, antiretroviral treatment (ART), tuberculosis care, and ambulatory primary care in Free State province, South Africa. Participants Fifteen clinics all implementing decentralisation and task shifting were randomised. The clinics cared for 400 000 general primary care patients and 10 136 patients in an HIV/AIDS/ART programme. There were 150 nurses. Intervention On-site outreach education in eight clinics; no such education in seven (control). Main outcome measures Provision of co-trimoxazole prophylaxis among patients referred to the HIV/AIDS/ART programme, and detection of cases of tuberculosis among those in the programme. Proportion of patients in the programme enrolled through general primary care consultations. Results Patients referred to the HIV/AIDS programme through general primary care at intervention clinics were more likely than those at control clinics to receive co-trimoxazole prophylaxis (41%, (2253/5523) v 32% (1340/4210); odds ratio 1.95, 95% confidence interval 1.11 to 3.40), and tuberculosis was more likely to be diagnosed among patients with HIV/AIDS/ART (7% (417/5793) v 6% (245/4343); 1.25, 1.01 to 1.55). Enrolment in the HIV/AIDS and ART programme through HIV testing in general primary care was not significantly increased (53% v 50%; 1.19, 0.51 to 2.77). Secondary outcomes were similar, except for weight gain, which was higher in the intervention group (2.3 kg v 1.9 kg, P<0.001). Conclusion Though outreach education is an effective and feasible strategy for improving comprehensiveness of care and wellbeing of patients with HIV/AIDS, there is no evidence that it increases access to the ART programme. It is now being widely implemented in South Africa. Trial registration Current Controlled Trials ISRCTN 24820584.

[1]  A D Oxman,et al.  Educational outreach visits: effects on professional practice and health care outcomes. , 2007, The Cochrane database of systematic reviews.

[2]  M. Chopra,et al.  Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. , 2005, American journal of public health.

[3]  R. Chaisson,et al.  Tuberculosis in Africa--combating an HIV-driven crisis. , 2008, The New England journal of medicine.

[4]  Mark Dybul,et al.  Rapid expansion of the health workforce in response to the HIV epidemic. , 2007, The New England journal of medicine.

[5]  Krista L. Dong,et al.  Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa. , 2007, The Journal of infectious diseases.

[6]  R. Wood.  The case for integrating tuberculosis and HIV treatment services in South Africa. , 2007, The Journal of infectious diseases.

[7]  E. Bateman,et al.  Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol , 2008, Trials.

[8]  D. Peters,et al.  Improving health service delivery in developing countries : from evidence to action , 2009 .

[9]  G. Kegels,et al.  Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt? , 2008, Social science & medicine.

[10]  L. Ferradini,et al.  Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. , 2004, AIDS.

[11]  E. Bateman,et al.  Expanding access to ART in South Africa: the role of nurse-initiated treatment. , 2010, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[12]  W. Van Damme,et al.  Rapid Scale-Up of Antiretroviral Treatment in Ethiopia: Successes and System-Wide Effects , 2009, PLoS medicine.

[13]  J. Frenk.  The Global Health System: Strengthening National Health Systems as the Next Step for Global Progress , 2010, PLoS medicine.

[14]  Katharina Kober,et al.  Scaling up access to antiretroviral treatment in southern Africa: who will do the job? , 2004, The Lancet.

[15]  E. Bateman,et al.  The Practical Approach to Lung Health in South Africa (PALSA) intervention: respiratory guideline implementation for nurse trainers. , 2006, International nursing review.

[16]  Cesar G Victora,et al.  How can we achieve and maintain high-quality performance of health workers in low-resource settings? , 2005, The Lancet.

[17]  L. J. Wei,et al.  Properties of the urn randomization in clinical trials. , 1988, Controlled clinical trials.

[18]  Barry Burciul,et al.  Strengthening health human resources and improving clinical outcomes through an integrated guideline and educational outreach in resource-poor settings: a cluster-randomized trial , 2010, Trials.

[19]  E. Bateman,et al.  Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial , 2005, BMJ : British Medical Journal.

[20]  A. Binagwaho,et al.  Task Shifting for Scale-up of HIV Care: Evaluation of Nurse-Centered Antiretroviral Treatment at Rural Health Centers in Rwanda , 2009, PLoS medicine.

[21]  B. Lambdin,et al.  Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case study , 2010, Journal of the International AIDS Society.

[22]  R. Steinbrook.  Closing the affordability gap for drugs in low-income countries. , 2007, The New England journal of medicine.

[23]  J. Lellouch,et al.  EXPLANATORY AND PRAGMATIC ATTITUDES IN THERAPEUTICAL TRIALS , 2003 .

[24]  E. Bateman,et al.  Effectiveness of antiretroviral treatment in a South African program: a cohort study. , 2008, Archives of internal medicine.

[25]  E. Schouten,et al.  Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  J. Lellouch,et al.  Explanatory and pragmatic attitudes in therapeutical trials. , 1967, Journal of chronic diseases.

[27]  S. Abdulla,et al.  Scaling up priority health interventions in Tanzania: the human resources challenge. , 2007, Health policy and planning.

[28]  D. Altman,et al.  CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.

[29]  Andy Haines,et al.  A framework for mandatory impact evaluation to ensure well informed public policy decisions , 2010, The Lancet.

[30]  D. Bradshaw,et al.  Identifying deaths from AIDS in South Africa , 2005, AIDS.

[31]  A. Mukhopadhyay,et al.  Health systems and services. , 1992, Health for the millions.

[32]  Jayanta Bhattacharya,et al.  The President's Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes , 2009, Annals of Internal Medicine.

[33]  Eric Goemaere,et al.  Integrating tuberculosis and HIV care in the primary care setting in South Africa , 2004, Tropical medicine & international health : TM & IH.

[34]  S. Reid,et al.  Strengthening Health Systems at Facility-Level: Feasibility of Integrating Antiretroviral Therapy into Primary Health Care Services in Lusaka, Zambia , 2010, PloS one.

[35]  N. Ford,et al.  Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. , 2007, The Journal of infectious diseases.

[36]  Milton C Weinstein,et al.  Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. , 2006, The New England journal of medicine.

[37]  E. Bateman,et al.  Building capacity for antiretroviral delivery in South Africa: A qualitative evaluation of the PALSA PLUS nurse training programme , 2008, BMC health services research.

[38]  R. Zachariah,et al.  Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea , 2008, The Lancet.